250 related articles for article (PubMed ID: 24307739)
1. MPYS/STING-mediated TNF-α, not type I IFN, is essential for the mucosal adjuvant activity of (3'-5')-cyclic-di-guanosine-monophosphate in vivo.
Blaauboer SM; Gabrielle VD; Jin L
J Immunol; 2014 Jan; 192(1):492-502. PubMed ID: 24307739
[TBL] [Abstract][Full Text] [Related]
2. MPYS is required for IFN response factor 3 activation and type I IFN production in the response of cultured phagocytes to bacterial second messengers cyclic-di-AMP and cyclic-di-GMP.
Jin L; Hill KK; Filak H; Mogan J; Knowles H; Zhang B; Perraud AL; Cambier JC; Lenz LL
J Immunol; 2011 Sep; 187(5):2595-601. PubMed ID: 21813776
[TBL] [Abstract][Full Text] [Related]
3. The mucosal adjuvant cyclic di-GMP enhances antigen uptake and selectively activates pinocytosis-efficient cells in vivo.
Blaauboer SM; Mansouri S; Tucker HR; Wang HL; Gabrielle VD; Jin L
Elife; 2015 Apr; 4():. PubMed ID: 25898005
[TBL] [Abstract][Full Text] [Related]
4.
Costa Franco MM; Marim F; Guimarães ES; Assis NRG; Cerqueira DM; Alves-Silva J; Harms J; Splitter G; Smith J; Kanneganti TD; de Queiroz NMGP; Gutman D; Barber GN; Oliveira SC
J Immunol; 2018 Jan; 200(2):607-622. PubMed ID: 29203515
[TBL] [Abstract][Full Text] [Related]
5. New MoDC-Targeting TNF Fusion Proteins Enhance Cyclic Di-GMP Vaccine Adjuvanticity in Middle-Aged and Aged Mice.
Gogoi H; Mansouri S; Katikaneni DS; Jin L
Front Immunol; 2020; 11():1674. PubMed ID: 32849581
[TBL] [Abstract][Full Text] [Related]
6. Immature lung TNFR2
Mansouri S; Patel S; Katikaneni DS; Blaauboer SM; Wang W; Schattgen S; Fitzgerald K; Jin L
Mucosal Immunol; 2019 Jan; 12(1):277-289. PubMed ID: 30327534
[TBL] [Abstract][Full Text] [Related]
7. STING is a direct innate immune sensor of cyclic di-GMP.
Burdette DL; Monroe KM; Sotelo-Troha K; Iwig JS; Eckert B; Hyodo M; Hayakawa Y; Vance RE
Nature; 2011 Sep; 478(7370):515-8. PubMed ID: 21947006
[TBL] [Abstract][Full Text] [Related]
8. Cyclic-di-GMP Induces STING-Dependent ILC2 to ILC1 Shift During Innate Type 2 Lung Inflammation.
Cavagnero KJ; Badrani JH; Naji LH; Amadeo MB; Leng AS; Lacasa LD; Strohm AN; Renusch SR; Gasparian SS; Doherty TA
Front Immunol; 2021; 12():618807. PubMed ID: 33679760
[TBL] [Abstract][Full Text] [Related]
9. TBK1 recruitment to STING activates both IRF3 and NF-κB that mediate immune defense against tumors and viral infections.
Yum S; Li M; Fang Y; Chen ZJ
Proc Natl Acad Sci U S A; 2021 Apr; 118(14):. PubMed ID: 33785602
[TBL] [Abstract][Full Text] [Related]
10. Single nucleotide polymorphisms of human STING can affect innate immune response to cyclic dinucleotides.
Yi G; Brendel VP; Shu C; Li P; Palanathan S; Cheng Kao C
PLoS One; 2013; 8(10):e77846. PubMed ID: 24204993
[TBL] [Abstract][Full Text] [Related]
11. Cytosolic-DNA-mediated, STING-dependent proinflammatory gene induction necessitates canonical NF-κB activation through TBK1.
Abe T; Barber GN
J Virol; 2014 May; 88(10):5328-41. PubMed ID: 24600004
[TBL] [Abstract][Full Text] [Related]
12. Sublingual targeting of STING with 3'3'-cGAMP promotes systemic and mucosal immunity against anthrax toxins.
Martin TL; Jee J; Kim E; Steiner HE; Cormet-Boyaka E; Boyaka PN
Vaccine; 2017 Apr; 35(18):2511-2519. PubMed ID: 28343781
[TBL] [Abstract][Full Text] [Related]
13. AdrA as a Potential Immunomodulatory Candidate for STING-Mediated Antiviral Therapy That Required Both Type I IFN and TNF-α Production.
Rodriguez-Garcia E; Zabaleta N; Gil-Farina I; Gonzalez-Aparicio M; Echeverz M; Bähre H; Solano C; Lasa I; Gonzalez-Aseguinolaza G; Hommel M
J Immunol; 2021 Jan; 206(2):376-385. PubMed ID: 33298616
[TBL] [Abstract][Full Text] [Related]
14. Cyclic GMP-AMP displays mucosal adjuvant activity in mice.
Škrnjug I; Guzmán CA; Rueckert C
PLoS One; 2014; 9(10):e110150. PubMed ID: 25295996
[TBL] [Abstract][Full Text] [Related]
15. TLR9 and STING agonists synergistically induce innate and adaptive type-II IFN.
Temizoz B; Kuroda E; Ohata K; Jounai N; Ozasa K; Kobiyama K; Aoshi T; Ishii KJ
Eur J Immunol; 2015 Apr; 45(4):1159-69. PubMed ID: 25529558
[TBL] [Abstract][Full Text] [Related]
16. STING Activator c-di-GMP-Loaded Mesoporous Silica Nanoparticles Enhance Immunotherapy Against Breast Cancer.
Chen YP; Xu L; Tang TW; Chen CH; Zheng QH; Liu TP; Mou CY; Wu CH; Wu SH
ACS Appl Mater Interfaces; 2020 Dec; 12(51):56741-56752. PubMed ID: 33305564
[TBL] [Abstract][Full Text] [Related]
17. c-di-GMP Induces COX-2 Expression in Macrophages in a STING-Independent Manner.
Wang M; Chaudhuri R; Ong WWS; Sintim HO
ACS Chem Biol; 2021 Sep; 16(9):1663-1670. PubMed ID: 34478263
[TBL] [Abstract][Full Text] [Related]
18. The N-ethyl-N-nitrosourea-induced Goldenticket mouse mutant reveals an essential function of Sting in the in vivo interferon response to Listeria monocytogenes and cyclic dinucleotides.
Sauer JD; Sotelo-Troha K; von Moltke J; Monroe KM; Rae CS; Brubaker SW; Hyodo M; Hayakawa Y; Woodward JJ; Portnoy DA; Vance RE
Infect Immun; 2011 Feb; 79(2):688-94. PubMed ID: 21098106
[TBL] [Abstract][Full Text] [Related]
19. Assessment of Th1/Th2 Bias of STING Agonists Coated on Microneedles for Possible Use in Skin Allergen Immunotherapy.
Shakya AK; Lee CH; Uddin MJ; Gill HS
Mol Pharm; 2018 Nov; 15(11):5437-5443. PubMed ID: 30299105
[TBL] [Abstract][Full Text] [Related]
20. Generation of Th1 and Th2 chemokines by human eosinophils: evidence for a critical role of TNF-alpha.
Liu LY; Bates ME; Jarjour NN; Busse WW; Bertics PJ; Kelly EA
J Immunol; 2007 Oct; 179(7):4840-8. PubMed ID: 17878383
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
